In a debate during a plenary session, Michael Saag, M.D., argued for more activism to make PrEP accessible to people who need it.
Activist Mark Hannay explains what the bill means for people living with HIV and how it will shape the 2020 election debate.
Drug pricing expert Tim Horn helps us make sense of the administration's future plans for the Medicare Part D and 340B programs.
We have no reason to trust President Trump's State of the Union announcement on HIV -- and that's precisely why we should work with the administration anyway, Drew Gibson contends.
While some HIV advocates are hopeful about the announcement, some worry that other Trump policies negate any real prospects for positive change.
In order to adequately address the HIV epidemic in the United States, two advocates argue that the high cost of antiretroviral drugs must be addressed.
HHS Secretary Azar's PACHA co-chair announcement disappoints but doesn't surprise community members.
The activists have big plans for using their techniques to pressure the new Congress into inching toward universal health care in the years ahead.
Tell the Department of Homeland Security that this hateful, harmful, and discriminatory policy is unacceptable before the public comment period ends on Dec. 10.